Constantino Fondevila

Prof. Constantino Fondevila

Hospital Universitario La Paz, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2003 in Experimental and Molecular Pathology
Verified
Journal Article
Closed access
CFConstantino Fondevila
Constantino Fondevila
RBRonald W Busuttil
Ronald W Busuttil
JKJerzy W Kupiec-Weglinski
Jerzy W Kupiec-Weglinski

6 March 2019 in Liver International
Verified
Journal Article
Open access
PDF file
UCUmberto Cillo
Umberto Cillo
CFConstantino Fondevila
Constantino Fondevila
MDMatteo Donadon
Matteo Donadon
Enrico GringeriEnrico Gringeri
Enrico Gringeri
FMFederico Mocchegiani
Federico Mocchegiani
BKBas Groot Koerkamp
Bas Groot Koerkamp
Surgical resection is the only potentially curative treatment for patients with cholangiocarcinoma. For both perihilar cholangiocarcinoma (pCCA) and intrahepatic cholangiocarcinoma (iCCA), 5‐year overall survival of about 30% has been reported in large series. This review addresses several challenges in surgical management of cholangiocarcinoma. The first challenge is diagnosis: a biopsy is typically avoided because of the risk of seeding metastases and the low yield of a brush of the bile duct. However, about 15% of patients with suspected pCCA are found to have a benign diagnosis after resection. The second challenge is staging; even with the best preoperative imaging, a substantial percentage of patients has occult metastatic disease detected at staging laparoscopy or early recurrence after resection. The third challenge is an adequate volume and function of the future liver remnant, which may require preoperative biliary drainage and portal vein embolization. The fourth challenge is a complete resection: a positive bile duct margin is not uncommon because the microscopic biliary extent of disease may be more extensive than perceived on imaging. The fifth challenge is the high post‐operative mortality that has decreased in very high volume Asian centres, but remains about 10% in many Western referral centres. The sixth challenge is that even after a complete resection most patients develop recurrent disease. Recent randomized controlled trials found conflicting results regarding the benefit of adjuvant chemotherapy. The final challenge is to determine which patients with cholangiocarcinoma should undergo liver transplantation rather than resection.

9 June 2007 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
CFConstantino Fondevila
Constantino Fondevila
AHA. J. Hessheimer
A. J. Hessheimer
ARA. Ruiz
A. Ruiz
DCD. Calatayud
D. Calatayud
JFJoana Ferrer
Joana Ferrer
JGJ. C. García‐Valdecasas
J. C. García‐Valdecasas
Donors after cardiac death (DCD) suffer irreversible cardiac arrest prior to donation. We describe our liver transplant experience with DCD whose cardiac arrest is unexpected, not following the removal of ventilatory support, whom we maintain with normothermic extracorporeal membrane oxygenation (NECMO). A potential donor goes into cardiac arrest outside the hospital and is brought to the hospital under continuous cardiopulmonary resuscitation (CPR). The donor is declared dead and placed on a cardiocompressor. Femoral vessels are cannulated and connected to cardiopulmonary bypass (CPB) to establish NECMO. Blood parameters and CPB pump flow are monitored throughout NECMO, which is continued until cold preservation. From April 2002 to May 2006, 10 of 40 potential DCD livers were transplanted. Only one graft was lost to primary nonfunction (PNF) and another to hepatic artery thrombosis. Posttransplant hepatic function was good. Certain parameters, such as CPR and NECMO times, hepatic transaminases during NECMO, and donor age, determined the viability of DCD liver grafts and were used to establish criteria for their acceptance. Though considered marginal, unexpected DCD can represent an important source of viable livers for transplant if strict acceptance criteria are employed and they are maintained with NECMO prior to recovery.

1 April 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
AHAmelia J. Hessheimer
Amelia J. Hessheimer
ECElisabeth Coll
Elisabeth Coll
FTFerran Torres
Ferran Torres
PRPatricia Ruíz
Patricia Ruíz
MGMikel Gastaca
Mikel Gastaca
CFConstantino Fondevila
Constantino Fondevila

1 January 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
JCJordi Colmenero
Jordi Colmenero
Manuel Rodríguez-PerálvarezManuel Rodríguez-Perálvarez
Manuel Rodríguez-Perálvarez
MSMagdalena Salcedo
Magdalena Salcedo
AAAna Arias-Milla
Ana Arias-Milla
AMAlejandro Muñoz-Serrano
Alejandro Muñoz-Serrano
JPJosé Antonio Pons
José Antonio Pons

1 October 2018 in Journal of Hepatology
Verified
Journal Article
Closed access
LBLuca Saverio Belli
Luca Saverio Belli
Giovanni PerriconeGiovanni Perricone
Giovanni Perricone
RARene Adam
Rene Adam
PCPaolo Angelo Cortesi
Paolo Angelo Cortesi
MSMario Strazzabosco
Mario Strazzabosco
CDChristophe Duvoux
Christophe Duvoux